Outcomes of thyroid dysfunction in people aged 80 years and older: an individual patient data meta-analysis of four prospective studies (TULIPS consortium).
Conclusions In community dwelling people aged 80 years and older, (sub-)clinical thyroid dysfunction was not associated with functional outcomes or mortality and may therefore be of limited clinical significance. PMID: 33012278 [PubMed - as supplied by publisher]
Authors: White M, Edwards R, Stanley J, Hoek J, Waa AM, Ouimet J, Quah AC, Fong GT PMID: 33032313 [PubMed - in process]
Authors: Stephens R PMID: 33032312 [PubMed - in process]
Authors: Havill J, Smales L PMID: 33032311 [PubMed - in process]
Authors: Nicolson MN, Flett JA PMID: 33032310 [PubMed - in process]
Authors: Au M, Walcott J, Apostolov R, Lewis D, Hassen AS PMID: 33032309 [PubMed - in process]
Authors: Jones L, Isenmen H PMID: 33032308 [PubMed - in process]
Authors: Schep LJ, Slaughter RJ, Glue P, Gee P Abstract Cannabis is one of the most widely used recreational drugs in the world. Tetrahydrocannabinol (THC) is the psychoactive principal constituent of the cannabis plant (Cannabis sativa). It is taken either orally or by inhalation, resulting in sedation, euphoria, relaxation and loss of social inhibition. Adverse effects from higher doses can include fear, distrust and a profound state of unease, hallucinations, ataxia, stupor and seizures. Long-term use can result in respiratory and cardiovascular toxicity and has been associated with a range of psychiatric condit...
Authors: Matti B, Zargar-Shoshtari K Abstract Prostate cancer represents a significant health burden worldwide. The cancer incidence had substantially increased since the introduction of prostate specific antigen (PSA) in cancer screening. This had led to considerable debates among health professionals and epidemiologists, since PSA as a screening tool seemed to be far from perfect. In New Zealand, the controversy was quite prominent in the last three decades, with some advocating the benefits of screening, while others concerned regarding the risk of harms. With the absence of an organised screening programme and ...
CONCLUSION: The proposed PHARMAC criteria will give access to these important drugs to those people with T2DM who will likely benefit the most. PMID: 33032305 [PubMed - in process]